| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Adjusted EBITDA Q4 | $3.9B (Q3: $3.84B) | $4.2B | +300M QoQ acceleration, new partnership record |
| Full Year Adjusted EBITDA | $15.5B (2024) | $16.0B (nearly) | +3% growth, partnership record |
| DCF Attributable to Partners Q4 | $1.9B (Q3 2025) | $2.0B | Consistent with Q4 2024 |
| Full Year DCF | $8.4B (2024) | $8.2B | -200M YoY decline despite EBITDA growth |
| Organic Growth CapEx 2025 | $4.6B guidance | $4.5B actual | 100M under revised guidance |
| 2026 Growth CapEx Guidance | $5B (Q3) | $5B-5.5B | Raised upper bound by 500M |
| 2026 EBITDA Guidance | $17.3B-17.7B | $17.45B-17.85B | Modest 150M raise at midpoint |
| NGL Segment EBITDA Q4 | $1.1B (Q3) | $1.1B | Flat despite record volumes |
| Midstream EBITDA Q4 | $751M (Q3) | $720M | -31M QoQ decline |
| Crude EBITDA Q4 | $746M (Q3) | $722M | -24M QoQ, -38M YoY decline |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.